Case Report: Use of Liposomal Amphotericin B in Low Doses in Patients With Visceral Leishmaniasis

Background: No consensus has been reached regarding the optimal therapy for visceral leishmaniasis (VL), which affects ~12 million people worldwide. Case Presentation: This report described four cases of VL encountered in the First Affiliated Hospital of Xi'an Jiaotong University between Octobe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Danfeng, Cao, Wenya, Liu, Xiaojing, Han, Qunying, Fan, Wanhu, Li, Guoliang, Xia, Han, Zhang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635719/
https://www.ncbi.nlm.nih.gov/pubmed/34869476
http://dx.doi.org/10.3389/fmed.2021.766400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635719/
https://www.ncbi.nlm.nih.gov/pubmed/34869476
http://dx.doi.org/10.3389/fmed.2021.766400

Ejemplares similares